GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JFL Life Sciences Ltd (NSE:JFLLIFE) » Definitions » YoY EBITDA Growth

JFL Life Sciences (NSE:JFLLIFE) YoY EBITDA Growth : -19.54% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is JFL Life Sciences YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. JFL Life Sciences's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -19.54%.

JFL Life Sciences's EBITDA per Share for the six months ended in Mar. 2024 was ₹1.51.

JFL Life Sciences YoY EBITDA Growth Historical Data

The historical data trend for JFL Life Sciences's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JFL Life Sciences YoY EBITDA Growth Chart

JFL Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
YoY EBITDA Growth
Get a 7-Day Free Trial 53.55 21.35 176.39 -0.37 -19.54

JFL Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial 53.55 21.35 176.39 -0.37 -19.54

JFL Life Sciences YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

JFL Life Sciences's YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (A: Mar. 2024 )
=(EBITDA per Share (A: Mar. 2024 )-EBITDA per Share (A: Mar. 2023 ))/ | EBITDA per Share (A: Mar. 2023 ) |
=(1.511-1.878)/ | 1.878 |
=-19.54 %

JFL Life Sciences's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 ) |
=(1.511-1.878)/ | 1.878 |
=-19.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JFL Life Sciences YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of JFL Life Sciences's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

JFL Life Sciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JFL Life Sciences Ltd (NSE:JFLLIFE) » Definitions » YoY EBITDA Growth
Comparable Companies
BOM:542678 BOM:537253 BOM:530057 BOM:524703 BOM:543963 BOM:542248 NSE:WALPAR BOM:524711 BOM:506919 BOM:530317 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Jodhpur Cross Road, 309, Satyam Mall, Opposite Saman Complex, Near Vishweshwar Mahadev Mandir, Settelite, Ahmedabad, GJ, IND, 380015
Website
https://www.jfllifesciences.com
JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.

JFL Life Sciences Headlines

No Headlines